MEDI 114-3-Amino benzo[d]isoxazoles as novel multitargeted receptor tyrosine kinase inhibitors

被引：0

作者：

Ji, Zhiqin ^{[1
]}

Ahmed, Asma A. ^{[2
]}

Albert, Daniel H. ^{[1
]}

Bouska, Jennifer J. ^{[1
]}

Bousquet, Peter F.

Cunha, George A. ^{[2
]}

Glaser, Keith B. ^{[1
]}

Johnson, Eric F. ^{[1
]}

Guo, Jun ^{[1
]}

Li, Junling ^{[1
]}

Marcotte, Patrick A. ^{[1
]}

Moskey, Maria D. ^{[2
]}

Pease, Lori J. ^{[1
]}

Soni, Nirupama B. ^{[1
]}

Stewart, Kent D. ^{[1
]}

Tapang, Paul ^{[1
]}

Yates, Melinda S. ^{[1
]}

Davidsen, Steven K. ^{[1
]}

Michaelides, Michael R. ^{[1
]}

机构：

[1] Abbott Labs, Global Pharmaceut Res & Dev, Abbott Pk, IL 60064 USA

[2] Abbott Biores Ctr, Worcester, MA 01605 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2006年 / 232卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

114-MEDI

引用

页数：1

共 50 条

[1] 3-amino-benzo[d]isoxazoles as novel multitargeted inhibitors of receptor tyrosine kinases
Ji, Zhiqin
Ahmed, Asma A.
Albert, Daniel H.
Bouska, Jennifer J.
Bousquet, Peter F.
Cunha, George A.
Diaz, Gilbert
Glaser, Keith B.
Guo, Jun
Harris, Christopher M.
Li, Junling
Marcotte, Patrick A.
Moskey, Maria D.
Oie, Tetsuro
Pease, Lori
Soni, Nirupama B.
Stewart, Kent D.
Davidsen, Steven K.
Michaelides, Michael R.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (05) : 1231 - 1241
[2] Thienopyrimidine ureas as novel and potent multitargeted receptor tyrosine kinase inhibitors
Dai, YJ
Guo, Y
Frey, RR
Ji, ZQ
Curtin, ML
Ahmed, AA
Albert, DH
Arnold, L
Arries, SS
Barlozzari, T
Bauch, JL
Bouska, JJ
Bousquet, PF
Cunha, GA
Glaser, KB
Guo, J
Li, JL
Marcotte, PA
Marsh, KC
Moskey, MD
Pease, LJ
Stewart, KD
Stoll, VS
Tapang, P
Wishart, N
Davidsen, SK
Michaelides, MR
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (19) : 6066 - 6083
[3] MEDI 360-Azaindazole ureas as potent VEGFR/PDGFR multitargeted receptor tyrosine kinase inhibitors
Dai, Yujia
Hartandi, Kresna
Albert, Daniel H.
Bouska, Jennifer J.
Bokofzer, Gait T.
Donawho, Cherrie K.
Glaser, Keith B.
Guo, Jun
Li, Junling
Marcotte, Patrick A.
Olson, Amanda M.
Osterling, Donald J.
Pease, Lori J.
Soni, Niru B.
Stewart, Kent D.
Tapang, Paul
Reuter, David R.
Davidsen, Steven K.
Michaelides, Michael R.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
[4] Rational Design of Multitargeted Tyrosine Kinase Inhibitors: A Novel Approach
Barchechath, Sylvie
Williams, Christopher
Saade, Khalil
Lauwagie, Sylvia
Jean-Claude, Bertrand
CHEMICAL BIOLOGY & DRUG DESIGN, 2009, 73 (04) : 380 - 387
[5] 1,4-Dihydroindeno[1,2-c]pyrazoles as novel multitargeted receptor tyrosine kinase inhibitors
Dinges, Jurgen
Ashworth, Kimba L.
Akritopolou-Zanze, Irini
Arnold, Lee D.
Baumeister, Steven A.
Bousquet, Peter F.
Cunha, George A.
Davidsen, Steven K.
Djuric, Stevan W.
Gracias, Vijaya J.
Michaelides, Michael R.
Rafferty, Paul
Sowin, Thomas J.
Stewart, Kent D.
Xia, Zhiren
Zhang, Henry Q.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (16) : 4266 - 4271
[6] MEDI 319-Pyrimido[4,5-b][1,4]diazepines as novel multitargeted inhibitors of receptor tyrosine kinases
Ji, Zhiqin
Gracias, Vijaya
Akritopoulou-Zanze, Irini
Albert, Daniel H.
Glaser, Keith B.
Marcotte, Patrick M.
Lori, Pease
Soni, Nirupama B.
Stewart, Kent D.
Djuric, Stevan W.
Davidsen, Steven K.
Michaelides, Michael R.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
[7] 7-Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted receptor tyrosine kinase inhibitors
Frey, Robin R.
Curtin, Michael L.
Albert, Daniel H.
Glaser, Keith B.
Pease, Lori J.
Soni, Niru B.
Bouska, Jennifer J.
Reuter, David
Stewart, Kent D.
Marcotte, Patrick
Bukofzer, Gail
Li, Junling
Davidsen, Steven K.
Michaelides, Michael R.
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) : 3777 - 3787
[8] Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats
Carter, Joanne J.
Fretwell, Laurice V.
Woolard, Jeanette
FASEB JOURNAL, 2017, 31 (03): : 1193 - 1203
[9] Multitargeted receptor tyrosine kinase inhibitors synergize with folate-hapten mediated immunotherapy in folate receptor positive cancers
Bandara, Nimalka A.
Low, Philip S.
CANCER RESEARCH, 2014, 74 (19)
[10] Novel FLT3 tyrosine kinase inhibitors
Levis, M
Small, D
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (12) : 1951 - 1962

← 1 2 3 4 5 →